Loading…
Bioceres Crop Solutions Corp. is projected to rise to $0.4653 by 2027, a +23% move from its current price of $0.3782. BIOX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/5/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 6 | $0.3667 | $0.3783 | $0.3903 | +0.03% |
| Aug 7 | $0.3621 | $0.3784 | $0.3955 | +0.06% |
| Aug 8 | $0.3586 | $0.3785 | $0.3996 | +0.09% |
| Aug 9 | $0.3557 | $0.3787 | $0.4031 | +0.12% |
| Aug 10 | $0.3532 | $0.3788 | $0.4062 | +0.15% |
| Aug 11 | $0.3509 | $0.3789 | $0.409 | +0.18% |
| Aug 12 | $0.3489 | $0.379 | $0.4117 | +0.21% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.3489 | $0.379 | $0.4117 | +0.21% |
| Week 2 | $0.3378 | $0.3798 | $0.4269 | +0.42% |
| Week 3 | $0.3298 | $0.3806 | $0.4392 | +0.63% |
| Week 4 | $0.3232 | $0.3814 | $0.45 | +0.84% |
| Week 5 | $0.3176 | $0.3822 | $0.4598 | +1.05% |
| Week 6 | $0.3127 | $0.383 | $0.469 | +1.26% |
| Week 7 | $0.3083 | $0.3838 | $0.4777 | +1.47% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Bioceres Crop Solutions Corp. is a basic materials company that develops and commercializes crop productivity solutions.
It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier and higher yielding crops, while the Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers, and it also offers HB4, a drought tolerant seed technology program.
Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina. The company operates in Argentina, Brazil, North America, Europe, the Middle East, South America, the United States, and internationally.
BIOX trades at $0.343, reflecting a micro-cap profile in the Basic Materials space.
The company has a market cap of $21.89M and is ranked 4618. These fundamentals frame a small-cap commodity-crop solutions company with a broad regional footprint.
Looking further ahead, the forecast projects the average price to rise over time, with 2026 at $0.343 on average and a 2050 horizon where the average reaches $1.14 and a maximum of $2.22, implying an ROI of up to 231.6 across the horizon.
A major floor 20.5% below — a decisive break under it would weaken the trend.
The nearest floor, 14.6% below — buyers have tended to step in here.
Price is pressing into resistance (0.1% away) — a breakout level to watch.
A major ceiling 76.6% above — clearing it would confirm fresh momentum.
Key BIOX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BIOX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.3615 | Buy | $0.3617 | Buy |
| MA 10 | $0.3474 | Buy | $0.354 | Buy |
| MA 20 | $0.3464 | Buy | $0.3522 | Buy |
| MA 50 | $0.3761 | Buy | $0.3828 | Sell |
| MA 100 | $0.4316 | Sell | $0.5163 | Sell |
| MA 200 | $0.8443 | Sell | $1.09 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 53.72 | Neutral |
| Stoch RSI (14) | 77.07 | Neutral |
| CCI (20) | 123.99 | Buy |
| Williams %R (14) | -22.36 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 6.31 | Buy |
| Bollinger %B (20,2) | 0.85 | Neutral |
| Stochastic %K (14) | 77.64 | Neutral |
| TRIX (15) | -0.38 | Sell |
| Awesome (5,34) | 0.01 | Buy |
| Ultimate (7,14,28) | 67.59 | Neutral |
| Momentum (10) | 0.02 | Buy |
| Aroon Osc (25) | 16.00 | Buy |
| Hull MA (9) | 0.38 | Sell |
| ADX (14) | 17.25 | Neutral |
| ATR (14) | 0.01 | Info |
The 30-day technical picture is Neutral, with RSI(14) at 40.
The trend indicators show the 50-day simple moving average at $0.3911 and the 200-day simple moving average at $0.8968, suggesting near-term consolidation rather than a decisive upmove.
Support sits at $0.325 and resistance at $0.428, with the 30-day price range spanning from $0.2788 to $0.422.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.323 | $0.3782 | $0.4847 | 0% | Neutral | |
| $0.3663 | $0.4653 | $0.6276 | +23% | Bullish | |
| $0.3475 | $0.4561 | $0.6419 | +21% | Bullish | |
| $0.343 | $0.4627 | $0.6728 | +22% | Bullish | |
| $0.33 | $0.4561 | $0.6816 | +21% | Bullish | |
| $0.318 | $0.4492 | $0.6875 | +19% | Neutral | |
| $0.3206 | $0.4623 | $0.7228 | +22% | Bullish | |
| $0.3345 | $0.4918 | $0.7837 | +30% | Bullish | |
| $0.3952 | $0.5918 | $0.96 | +56% | Bullish | |
| $0.4206 | $0.6409 | $1.06 | +69% | Bullish | |
| $0.4389 | $0.725 | $1.28 | +92% | Bullish | |
| $0.7152 | $1.36 | $2.65 | +260% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.323 | $0.3782 | $0.446 | +0.00% |
| September 2026 | $0.3213 | $0.3813 | $0.4662 | +0.82% |
| October 2026 | $0.3248 | $0.3886 | $0.4811 | +1.92% |
| November 2026 | $0.3152 | $0.3796 | $0.4746 | -2.32% |
| December 2026 | $0.3172 | $0.3842 | $0.4847 | +1.20% |
Click any year to see its month-by-month BIOX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The BIOX price prediction for 2026 points to an average of $0.3782 (low $0.323, high $0.4847) — a potential gain of 0% on today's $0.3782. A consolidation phase looks the most probable path here.
In 2027, BIOX is projected to trade between $0.3663 and $0.6276, averaging $0.4653 — a potential gain of +23% from today's $0.3782. That is up +23% on the projected 2026 average. Momentum favours further upside here.
Bioceres Crop Solutions Corp.'s 2028 outlook centres on $0.4561, within a $0.3475 to $0.6419 range. That is -2% versus the projected 2027 average. That marks a +21% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, BIOX could reach as high as $0.6728, with a base case around $0.4627 and support toward $0.343 — roughly +22% from $0.3782. Momentum favours further upside here.
Expect BIOX to range from $0.33 to $0.6816 through 2030. The $0.4561 average target implies a +21% move from current prices. That is -1% versus the projected 2029 average. Buyers look set to stay in control over this stretch.
The BIOX price prediction for 2031 points to an average of $0.4492 (low $0.318, high $0.6875) — a potential gain of +19% on today's $0.3782. Price action looks broadly range-bound.
In 2032, BIOX is projected to trade between $0.3206 and $0.7228, averaging $0.4623 — a potential gain of +22% from today's $0.3782. That is up +3% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Bioceres Crop Solutions Corp.'s 2033 outlook centres on $0.4918, within a $0.3345 to $0.7837 range. That is up +6% on the projected 2032 average. That marks a +30% change versus current levels. Momentum favours further upside here.
By 2034, BIOX could reach as high as $0.96, with a base case around $0.5918 and support toward $0.3952 — roughly +56% from $0.3782. Buyers look set to stay in control over this stretch.
Expect BIOX to range from $0.4206 to $1.06 through 2035. The $0.6409 average target implies a +69% move from current prices. That is up +8% on the projected 2034 average. Momentum favours further upside here.
The BIOX price prediction for 2040 points to an average of $0.725 (low $0.4389, high $1.28) — a potential gain of +92% on today's $0.3782. Buyers look set to stay in control over this stretch.
In 2050, BIOX is projected to trade between $0.7152 and $2.65, averaging $1.36 — a potential gain of +260% from today's $0.3782. That is up +88% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in BIOX today (≈ 2,644.103649 BIOX) could be worth
$3,598.14
+$2,598.14 (+260%) by 2050 · US Dollar
Based on the average projected BIOX price of $1.36 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BIOXwould be worth at today's price.
$1,000 invested in BIOX on Aug 5, 2025 (≈ 278.551539 BIOX) would be worth
$105.35
-$894.65 (-89.5%) today · 0.11× · US Dollar
Based on a BIOX entry price of $3.59 vs. today's $0.3782.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.323 | $1,170.9 | +17.1% |
| 1 month ago | $0.359 | $1,053.48 | +5.3% |
| 3 months ago | $0.473 | $799.58 | -20.0% |
| 6 months ago | $0.565 | $669.38 | -33.1% |
| 1 year ago | $3.59 | $105.35 | -89.5% |
| All time (5.0y) ago | $14.2 | $26.63 | -97.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BIOX forecast.
Our base-case forecast reaches $0.76 around 2050.
Implied market cap at $0.76: $48.5M
The multi-year forecast shows a gradual rise in average prices and several bullish years. For example, 2027 projects an average of $0.417 with a max of $0.5637 and a 21.6 (in the forecast) outlook, signaling a bullish tilt for that year.
Further out, 2034 offers an average of $0.4932 with a max of $0.8016 and a 43.8 outlook, while 2035 carries an average of $0.553 with a max of $0.9136 and a 61.2 outlook, both described as bullish.
By 2040, the forecast shows an average of $0.5843 with a max of $1.03 and a 70.3 outlook, and by 2050 an average of $1.14 with a max of $2.22 and a 231.6 outlook. These figures imply a long-run upside under a bullish cadence, alongside periods of neutrality in earlier years.
Tap a question to reveal the answer.
In 2030, the forecast shows min $0.2936, avg $0.4065, max $0.6087, ROI 18.5, sentiment NEUTRAL.
Forecasts include neutral and bullish years, with examples such as 2027 avg $0.417 (ROI 21.6) and 2050 avg $1.14 (ROI 231.6). These are estimates, not guarantees.
Yes. The forecast projects a max of $2.22 by 2050, and an average of $1.14 by 2050.
The current price is $0.343.
The 30-day range runs from $0.2788 to $0.422.
Bioceres Crop Solutions Corp. Community Discussion
0Share your Bioceres Crop Solutions Corp. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.